Press "Enter" to skip to content

New patent expiration for Abbvie drug ANDROGEL

3
Copyright © DrugPatentWatch. Originally published at New patent expiration for Abbvie drug ANDROGEL

Annual Drug Patent Expirations for ANDROGEL
Annual Drug Patent Expirations for ANDROGEL

Androgel is a drug marketed by Abbvie and is included in two NDAs. It is available from two suppliers. There are eleven patents protecting this drug and three Paragraph IV challenges.

ANDROGEL drug price trends.

Drug patent litigation for ANDROGEL.

This drug has thirty-five patent family members in twenty-nine countries.

The generic ingredient in ANDROGEL is testosterone. Two suppliers are listed for this compound. Additional details are available on the testosterone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Abbvie drug ANDROGEL

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions